- Aug 2022
-
www.who.int www.who.int
-
COVID-19 vaccine tracker and landscape. (2022, April 22). https://www.who.int/publications/m/item/draft-landscape-of-covid-19-candidate-vaccines
-
-
www.medrxiv.org www.medrxiv.org
-
Regev-Yochay, G., Gonen, T., Gilboa, M., Mandelboim, M., Indenbaum, V., Amit, S., Meltzer, L., Asraf, K., Cohen, C., Fluss, R., Biber, A., Nemet, I., Kliker, L., Joseph, G., Doolman, R., Mendelson, E., Freedman, L. S., Harats, D., Kreiss, Y., & Lustig, Y. (2022). 4th Dose COVID mRNA Vaccines’ Immunogenicity & Efficacy Against Omicron VOC (p. 2022.02.15.22270948). medRxiv. https://doi.org/10.1101/2022.02.15.22270948
-
-
twitter.com twitter.com
-
Gavi, the Vaccine Alliance. (2021, November 25). Around the world, there are now 132 COVID-19 vaccine candidates undergoing clinical trials and 194 candidates in pre-clinical development. Read our latest #COVID19 vaccine race update: Https://t.co/ETtHP6XmYI [Tweet]. @gavi. https://twitter.com/gavi/status/1463953132120010753
-
- Mar 2022
-
www.news18.com www.news18.com
-
Corbevax: All About India’s First Protein Sub-Unit Covid Vaccine to be Given to 12-14 Age Group From Today. (2022, March 16). News18. https://www.news18.com/news/india/corbevax-all-about-indias-first-protein-sub-unit-covid-vaccine-to-be-given-to-12-14-age-group-from-today-4874345.html
-
- Feb 2022
-
twitter.com twitter.com
-
Ali Ellebedy. (2021, December 30). We need those who are adept at #SciComm to explain that “Omicron” is sufficiently different from the original strain that was used to make the vaccine. Therefore, the definition of “fully vaccinated” will have to be updated, but that does not mean that the vaccines have failed. [Tweet]. @TheBcellArtist. https://twitter.com/TheBcellArtist/status/1476649138691444740
-
-
www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
-
Afkhami, S., D’Agostino, M. R., Zhang, A., Stacey, H. D., Marzok, A., Kang, A., Singh, R., Bavananthasivam, J., Ye, G., Luo, X., Wang, F., Ang, J. C., Zganiacz, A., Sankar, U., Kazhdan, N., Koenig, J. F. E., Phelps, A., Gameiro, S. F., Tang, S., … Xing, Z. (2022). Respiratory mucosal delivery of next-generation COVID-19 vaccine provides robust protection against both ancestral and variant strains of SARS-CoV-2. Cell, S0092867422001453. https://doi.org/10.1016/j.cell.2022.02.005
-
-
www.theguardian.com www.theguardian.com
-
Devlin, H., & correspondent, H. D. S. (2022, February 3). Novavax Covid vaccine approved for use in over-18s in UK. The Guardian. https://www.theguardian.com/society/2022/feb/03/novavax-covid-vaccine-approved-for-use-in-over-18s-in-uk
-
- Dec 2021
-
twitter.com twitter.com
-
Eric Topol. (2020, November 28). This will go down in history as one of science and medical research’s greatest achievements. Perhaps the most impressive. I put together a preliminary timeline of some key milestones to show how several years of work were compressed into months. Https://t.co/BPcaZwDFkl [Tweet]. @EricTopol. https://twitter.com/EricTopol/status/1332771238771630080
-
-
www.nature.com www.nature.com
-
Mallapaty, S., Callaway, E., Kozlov, M., Ledford, H., Pickrell, J., & Van Noorden, R. (2021). How COVID vaccines shaped 2021 in eight powerful charts. Nature. https://doi.org/10.1038/d41586-021-03686-x
-
-
www.theguardian.com www.theguardian.com
-
Devlin, H., & Kollewe, J. (2021, November 26). BioNTech says it could tweak Covid vaccine in 100 days if needed. The Guardian. https://www.theguardian.com/society/2021/nov/26/biontech-says-it-could-tweak-covid-vaccine-in-100-days-if-needed
Tags
- science
- BioNTech
- transmissibility
- escape variant
- Pfizer
- is:news
- vaccine
- variant-specific booster
- immunity
- Omicron
- effectiveness
- lang:en
- booster
- clinical trials
- mutation
- development
- COVID-19
- protection
- spike protein
- variant
- research
Annotators
URL
theguardian.com/society/2021/nov/26/biontech-says-it-could-tweak-covid-vaccine-in-100-days-if-needed -
- Nov 2021
-
www.nature.com www.nature.com
-
Reardon, S. (2021). Cuba’s bet on home-grown COVID vaccines is paying off. Nature. https://doi.org/10.1038/d41586-021-03470-x
-
-
www.science.org www.science.org
-
Couzin-Frankel, J. (2021). Antiviral pills could change pandemic’s course. Science, 374(6569), 799–800. https://doi.org/10.1126/science.acx9605
-
- Oct 2021
-
www.nature.com www.nature.com
-
Mallapaty, S. (2021). The search for people who never get COVID. Nature. https://doi.org/10.1038/d41586-021-02978-6
-
-
www.fda.gov www.fda.gov
-
Zotero doesn't work on this site
-
-
-
Abbas-Hanif, A., Modi, N., Smith, S. K., & Majeed, A. (2021). Covid-19 treatments and vaccines must be evaluated in pregnancy. BMJ, n2377. https://doi.org/10.1136/bmj.n2377
-
-
www.gavi.org www.gavi.org
-
The COVID-19 vaccine race | Gavi, the Vaccine Alliance. (n.d.). Retrieved October 8, 2021, from https://www.gavi.org/vaccineswork/covid-19-vaccine-race
-
-
www.tagesschau.de www.tagesschau.de
-
tagesschau.de. (n.d.). Entwicklung von Impfstoffen: Komplett verdrehte Aussage. tagesschau.de. Retrieved March 2, 2021, from https://www.tagesschau.de/faktenfinder/merck-impfstoff-immunitaet-105.html
-
- Sep 2021
-
academic.oup.com academic.oup.com
-
Ortiz, J. R., & Neuzil, K. M. (2019). Influenza Immunization in Low- and Middle-Income Countries: Preparing for Next-Generation Influenza Vaccines. The Journal of Infectious Diseases, 219(Supplement_1), S97–S106. https://doi.org/10.1093/infdis/jiz024
-
- Aug 2021
-
www.medrxiv.org www.medrxiv.org
-
Thorpe, A., Fagerlin, A., Butler, J., Stevens, V., Drews, F. A., Shoemaker, H., Riddoch, M., & Scherer, L. D. (2021). Communicating about COVID-19 vaccine development and safety [Preprint]. Public and Global Health. https://doi.org/10.1101/2021.06.25.21259519
-
-
psyarxiv.com psyarxiv.com
-
Jørgensen, Frederik Juhl, Alexander Bor, and Michael Bang Petersen. ‘How the Development, Features and Roll-Out of a SARS-COV-2 Vaccine Shape Public Acceptance: A Conjoint Experiment in a Large Representative Sample of Danes’. PsyArXiv, 28 June 2021. https://doi.org/10.31234/osf.io/4y8ap.
-
-
www.nature.com www.nature.com
-
Rella, S. A., Kulikova, Y. A., Dermitzakis, E. T., & Kondrashov, F. A. (2021). Rates of SARS-CoV-2 transmission and vaccination impact the fate of vaccine-resistant strains. Scientific Reports, 11(1), 15729. https://doi.org/10.1038/s41598-021-95025-3
-
- Jul 2021
-
audiovisual.ec.europa.eu audiovisual.ec.europa.eu
-
EC AV PORTAL. (n.d.). Retrieved 29 July 2021, from https://audiovisual.ec.europa.eu/en/video/I-202865
-
- Jun 2021
-
www.nature.com www.nature.com
-
Subbaraman, N. (2021). This COVID-vaccine designer is tackling vaccine hesitancy—In churches and on Twitter. Nature, 590(7846), 377–377. https://doi.org/10.1038/d41586-021-00338-y
-
-
www.bmj.com www.bmj.com
-
Mahase, E. (2021). Covid-19: Where are we on vaccines and variants? BMJ, n597. https://doi.org/10.1136/bmj.n597
-
-
www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
-
Nandi, A., Kumar, S., Shet, A., Bloom, D. E., & Laxminarayan, R. (2020). Childhood vaccinations and adult schooling attainment: Long-term evidence from India’s Universal Immunization Programme. Social Science & Medicine (1982), 250, 112885. https://doi.org/10.1016/j.socscimed.2020.112885
-
- May 2021
-
www.nature.com www.nature.com
-
Khoury, D. S., Cromer, D., Reynaldi, A., Schlub, T. E., Wheatley, A. K., Juno, J. A., Subbarao, K., Kent, S. J., Triccas, J. A., & Davenport, M. P. (2021). Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection. Nature Medicine, 1–7. https://doi.org/10.1038/s41591-021-01377-8
-
-
lessonsfromthecrisis.substack.com lessonsfromthecrisis.substack.com
-
It’s bizarre that this needs saying, but of course the UK had a Herd Immunity plan—Lessons From The Crisis. (n.d.). Retrieved May 28, 2021, from https://lessonsfromthecrisis.substack.com/p/its-bizarre-that-this-needs-saying
-
-
blogs.bmj.com blogs.bmj.com
-
Optimising covid-19 vaccine uptake—Time for a more nuanced approach. (2021, April 30). The BMJ. https://blogs.bmj.com/bmj/2021/04/30/optimising-covid-19-vaccine-uptake-time-for-a-more-nuanced-approach/
-
-
psyarxiv.com psyarxiv.com
-
Chen, I.-H., Ahorsu, D. K., Ko, N.-Y., Yen, C.-F., Lin, C.-Y., Griffiths, M., & Pakpour, A. (2021). The development and validation of the Motors of COVID-19 Vaccination Acceptance Scale: Psychometric evaluation among mainland Chinese university students. PsyArXiv. https://doi.org/10.31234/osf.io/abfp6
-
-
rs-delve.github.io rs-delve.github.io
-
Initiative, T. D. (2020). SARS-CoV-2 Vaccine Development & Implementation; Scenarios, Options, Key Decisions. https://rs-delve.github.io/reports/2020/10/01/covid19-vaccination-report.html
-
- Mar 2021
-
www.thelancet.com www.thelancet.com
-
Dodd, R. H., Pickles, K., Nickel, B., Cvejic, E., Ayre, J., Batcup, C., Bonner, C., Copp, T., Cornell, S., Dakin, T., Isautier, J., & McCaffery, K. J. (2020). Concerns and motivations about COVID-19 vaccination. The Lancet Infectious Diseases, 0(0). https://doi.org/10.1016/S1473-3099(20)30926-9
-
-
science.sciencemag.org science.sciencemag.org
-
Graham, B. S. (2020). Rapid COVID-19 vaccine development. Science, 368(6494), 945–946. https://doi.org/10.1126/science.abb8923
-
-
www.bmj.com www.bmj.com
-
Pimenta, Dominic, Christian Yates, Christina Pagel, and Deepti Gurdasani. ‘Delaying the Second Dose of Covid-19 Vaccines’. BMJ 372 (18 March 2021): n710. https://doi.org/10.1136/bmj.n710.
-
-
www.theguardian.com www.theguardian.com
-
the Guardian. ‘Small Number of Facebook Users Responsible for Most Covid Vaccine Skepticism – Report’, 16 March 2021. http://www.theguardian.com/technology/2021/mar/15/facebook-study-covid-vaccine-skepticism.
-
-
www.pewresearch.org www.pewresearch.org
-
NW, 1615 L. St, Suite 800Washington, and DC 20036USA202-419-4300 | Main202-857-8562 | Fax202-419-4372 | Media Inquiries. ‘Intent to Get a COVID-19 Vaccine Rises to 60% as Confidence in Research and Development Process Increases’. Pew Research Center Science & Society (blog), 3 December 2020. https://www.pewresearch.org/science/2020/12/03/intent-to-get-a-covid-19-vaccine-rises-to-60-as-confidence-in-research-and-development-process-increases/.
-
- Feb 2021
-
twitter.com twitter.com
-
Andrew💙Croxford. (2020, December 3). NEW THREAD: possible development of anti-Syncytin responses after immunization with the SARS-CoV-2 spike protein-coding mRNA vaccines, based on a ‘homologous’ region shared between these proteins. [Tweet]. @andrew_croxford. https://twitter.com/andrew_croxford/status/1334593606196187136
-
-
-
Study shows vaccine nationalism could cost rich countries US$4.5 trillion. (2021, January 25). ICC - International Chamber of Commerce. https://iccwbo.org/media-wall/news-speeches/study-shows-vaccine-nationalism-could-cost-rich-countries-us4-5-trillion/
Tags
- vaccination
- nationalism
- funding
- lang:en
- global
- economy
- economic
- government
- treatment
- development
- COVID-19
- is:news
- vaccine
- ICC
- model
Annotators
URL
-
-
www.scientificamerican.com www.scientificamerican.com
-
Cormier, Z. (n.d.). The Second-Generation COVID Vaccines Are Coming. Scientific American. Retrieved 11 February 2021, from https://www.scientificamerican.com/article/the-second-generation-covid-vaccines-are-coming/
-
-
www.oecd-forum.org www.oecd-forum.org
-
Network, T. O. F. (2021, February 8). The Haves and Have-Nots: The geopolitical dilemma of COVID vaccine equity. The OECD Forum Network. http://www.oecd-forum.org/posts/the-haves-and-have-nots-the-geopolitical-dilemma-of-covid-vaccine-equity
-
- Jan 2021
-
www.theatlantic.com www.theatlantic.com
-
Zhang, S. (2020, November 10). The Lame-Duck Vaccine. The Atlantic. https://www.theatlantic.com/health/archive/2020/11/bidens-vaccine-reset/617059/
-
- Sep 2020
-
twitter.com twitter.comTwitter1
-
Natalie E. Dean en Twitter: “VACCINE EFFICACY 101: A biostatistician's primer. Ten tweets to cover:- How is vaccine efficacy calculated?- Distinguishing between infection, disease, & severe disease.- Measuring reduced infectiousness.- Vaccine efficacy vs. effectiveness!n” / Twitter. (n.d.). Twitter. Retrieved September 30, 2020, from https://twitter.com/nataliexdean/status/1310613702476017666
-
-
www.nihr.ac.uk www.nihr.ac.uk
-
Over 250,000 volunteers now registered for new COVID-19 vaccine trials as recruitment begins for Novavax study. (n.d.). Retrieved September 28, 2020, from https://www.nihr.ac.uk/news/over-250000-volunteers-now-registered-for-new-covid-19-vaccine-trials-as-recruitment-begins-for-novavax-study/25731
Tags
- vaccine development
- effectiveness
- lang:en
- volunteer
- UK
- phase three
- COVID-19
- Novavax
- is:news
- safety
- immunology
- research
Annotators
URL
-
-
www.nature.com www.nature.com
-
magazine, D. C., Smriti Mallapaty,Nature. (n.d.). Coronavirus Vaccine U.K. Trial Restarts, But Scientists Question Lack of Transparency. Scientific American. Retrieved September 16, 2020, from https://www.scientificamerican.com/article/coronavirus-vaccine-u-k-trial-restarts-but-scientists-question-lack-of-transparency/
-
-
www.thelancet.com www.thelancet.com
-
Diseases, T. L. I. (2020). Curing COVID-19. The Lancet Infectious Diseases, 0(0). https://doi.org/10.1016/S1473-3099(20)30706-4
-
- Aug 2020
-
-
Felipe, L. S., Vercruysse, T., Sharma, S., Ma, J., Lemmens, V., Looveren, D. van, Javarappa, M. P. A., Boudewijns, R., Malengier-Devlies, B., Kaptein, S. F., Liesenborghs, L., Keyzer, C. D., Bervoets, L., Rasulova, M., Seldeslachts, L., Jansen, S., Yakass, M. B., Quaye, O., Li, L.-H., … Dallmeier, K. (2020). A single-dose live-attenuated YF17D-vectored SARS-CoV2 vaccine candidate. BioRxiv, 2020.07.08.193045. https://doi.org/10.1101/2020.07.08.193045
-
-
www.scientificamerican.com www.scientificamerican.com
-
Barber, C. (n.d.). ‘Instant Coffee’ COVID-19 Tests Could Be the Answer to Reopening the U.S. Scientific American. Retrieved August 27, 2020, from https://www.scientificamerican.com/article/instant-coffee-covid-19-tests-could-be-the-answer-to-reopening-the-u-s/
-
-
www.newscientist.com www.newscientist.com
-
Marshall, M. (n.d.). Everything you need to know about Russia’s coronavirus vaccine claims. New Scientist. Retrieved August 18, 2020, from https://www.newscientist.com/article/2251722-everything-you-need-to-know-about-russias-coronavirus-vaccine-claims/
Tags
- Russia
- lang:en
- bad science
- efficacy
- concern
- public health
- development
- COVID-19
- strategy
- is:news
- safety
- vaccine
- spike protein
- transparency
- immunology
Annotators
URL
-
-
www.nber.org www.nber.org
-
Lo, A. W., Siah, K. W., & Wong, C. H. (2020). Estimating Probabilities of Success of Vaccine and Other Anti-Infective Therapeutic Development Programs (Working Paper No. 27176; Working Paper Series). National Bureau of Economic Research. https://doi.org/10.3386/w27176
-
-
www.theatlantic.com www.theatlantic.com
-
A Vaccine Reality Check. (n.d.). MSN. Retrieved August 9, 2020, from https://www.msn.com/en-us/news/us/a-vaccine-reality-check/ar-BB178Yaf
-
-
www.cnn.com www.cnn.com
-
CNN, J. G., Naomi Thomas, Dana Vigue and Jacqueline Howard. (n.d.). Oxford’s Covid-19 vaccine appears safe and induces immune response, early results suggest. CNN. Retrieved August 2, 2020, from https://www.cnn.com/2020/07/20/health/oxford-covid-19-vaccine-results-cansino-pfizer-study/index.html
-
- Jul 2020
-
-
Younes, G. A., Ayoubi, C., Ballester, O., Cristelli, G., de Rassenfosse, G., Foray, D., Gaule, P., Pellegrino, G., van den Heuvel, M., Webster, B., & Zhou, L. (2020). COVID-19_Insights from Innovation Economists [Preprint]. SocArXiv. https://doi.org/10.31235/osf.io/b5zae
-
-
-
Younes, G. A., Ayoubi, C., Ballester, O., Cristelli, G., de Rassenfosse, G., Foray, D., Gaule, P., van den Heuvel, M., Webster, B., & Zhou, L. (2020). COVID-19: Insights from Innovation Economists (with French executive summary) [Preprint]. SocArXiv. https://doi.org/10.31235/osf.io/65pgr
-
-
-
Sehgal, D. (2020). Analysis of Vaccines to tackle COVID-19 with Patent Review [Preprint]. SocArXiv. https://doi.org/10.31235/osf.io/q96wj
-
-
www.statnews.com www.statnews.com
-
Herper, M. (2020, July 1). Covid-19 vaccine from Pfizer and BioNTech shows positive results. CNBC. https://www.cnbc.com/2020/07/01/coronavirus-vaccine-from-pfizer-and-biontech-shows-positive-results-report-says.html
-
-
www.nationalgeographic.com www.nationalgeographic.com
-
A COVID-19 vaccine has passed its first human trial. But is it the frontrunner? (2020, May 29). Science. https://www.nationalgeographic.com/science/2020/05/coronavirus-vaccine-passes-first-human-trial-but-is-it-frontrunner-cvd/
-
-
-
Richards, A. D. (2020). Ethical Guidelines for Deliberately Infecting Volunteers with COVID-19 [Preprint]. SocArXiv. https://doi.org/10.31235/osf.io/jb7gq
-
-
www.biorxiv.org www.biorxiv.org
-
Corbett, K. S., Edwards, D., Leist, S. R., Abiona, O. M., Boyoglu-Barnum, S., Gillespie, R. A., Himansu, S., Schäfer, A., Ziwawo, C. T., DiPiazza, A. T., Dinnon, K. H., Elbashir, S. M., Shaw, C. A., Woods, A., Fritch, E. J., Martinez, D. R., Bock, K. W., Minai, M., Nagata, B. M., … Graham, B. S. (2020). SARS-CoV-2 mRNA Vaccine Development Enabled by Prototype Pathogen Preparedness. BioRxiv, 2020.06.11.145920. https://doi.org/10.1101/2020.06.11.145920
-
- Jun 2020
-
www.biorxiv.org www.biorxiv.org
-
Robbiani, D. F., Gaebler, C., Muecksch, F., Lorenzi, J. C. C., Wang, Z., Cho, A., Agudelo, M., Barnes, C. O., Gazumyan, A., Finkin, S., Hagglof, T., Oliveira, T. Y., Viant, C., Hurley, A., Hoffmann, H.-H., Millard, K. G., Kost, R. G., Cipolla, M., Gordon, K., … Nussenzweig, M. C. (2020). Convergent Antibody Responses to SARS-CoV-2 Infection in Convalescent Individuals [Preprint]. Immunology. https://doi.org/10.1101/2020.05.13.092619
-
-
www.vox.com www.vox.com
-
Matthews, D. (2020, May 20). How exposing healthy volunteers to Covid-19 for vaccine testing would work. Vox. https://www.vox.com/future-perfect/2020/5/20/21258725/covid-19-human-challenge-trials-vaccine-update-sars-cov-2
-
- May 2020
-
www.sciencedirect.com www.sciencedirect.com
-
Grifoni, A., Weiskopf, D., Ramirez, S. I., Mateus, J., Dan, J. M., Moderbacher, C. R., Rawlings, S. A., Sutherland, A., Premkumar, L., Jadi, R. S., Marrama, D., de Silva, A. M., Frazier, A., Carlin, A., Greenbaum, J. A., Peters, B., Krammer, F., Smith, D. M., Crotty, S., & Sette, A. (2020). Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals. Cell, S0092867420306103. https://doi.org/10.1016/j.cell.2020.05.015
-
- Apr 2020
-
sciencebusiness.net sciencebusiness.net
-
EU boosts efforts to adjust R&D programmes to virus crisis. (n.d.). Science|Business. Retrieved April 15, 2020, from https://sciencebusiness.net/news/eu-boosts-efforts-adjust-rd-programmes-virus-crisis
-